MDL

Medline, Inc. (MDLN) Q1 2026 Earnings

MDLN·Reported May 6, 2026·Before market open

Medline, Inc. reported Q1 2026 revenue of $7.4B, beat analyst consensus of $7.2B by $189.4M. Diluted EPS came in at $0.33, beat the $0.30 consensus by $0.03. Medline, Inc. reports across 2 business segments, led by Medline Brand and Supply Chain Solutions.

Revenue
$7.4Bbeat by $189.4M
Consensus: $7.2B
Diluted EPS
$0.33beat by $0.03
Consensus: $0.30
SEC

SEC Filings

Financial Snapshot

Trailing eight quarters through Q1 2026

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2026 Earnings FAQ

Common questions about Medline, Inc. 's Q1 2026 earnings report.

Medline, Inc. (MDLN) reported Q1 2026 earnings on May 6, 2026 before market open.

Medline, Inc. reported revenue of $7.4B and diluted EPS of $0.33 for Q1 2026.

Revenue beat the consensus estimate of $7.2B by $189.4M. EPS beat the consensus estimate of $0.30 by $0.03.

You can read the 8-K earnings release (0002046386-26-000022) and the 10-Q periodic report (0002046386-26-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.